Last update 08 May 2025

DMT-210

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [5]
Target
GPCR x IL-6 x IL-8 x TLR2 x TNF-α
Action
modulators, inhibitors, antagonists
Mechanism
GPCR modulators(G-protein coupled receptor modulators), IL-6 inhibitors(Interleukin-6 inhibitors), IL-8 inhibitors(Interleukin-8 inhibitors)
+ [2]
Therapeutic Areas
Immune System DiseasesCongenital DisordersSkin and Musculoskeletal Diseases
Active Indication
Dermatitis, AtopicRosacea
Inactive Indication
Mild Atopic DermatitisModerate Atopic Dermatitis
Originator Organization
Signum Dermalogix, Inc.
Active Organization
Signum Dermalogix, Inc.
Inactive Organization
Dermata Therapeutics, Inc.Dermata Therapeutics, Inc.
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with DMT-210
NCT03003104
/ CompletedPhase 2
A Randomized, Double-Blind, Vehicle Controlled Study To Evaluate The Safety, Tolerability, And Efficacy Of DMT210 Gel In Adult Patients With Moderate To Severe Acne Rosacea
NCT02949960
/ CompletedPhase 2
DMT210 Topical Gel in the Treatment of Mild to Moderate Atopic Dermatitis
100 Clinical Results associated with DMT-210
Login to view more data
100 Translational Medicine associated with DMT-210
Login to view more data
100 Patents (Medical) associated with DMT-210
Login to view more data
100 Deals associated with DMT-210
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dermatitis, AtopicPhase 2-
Signum Dermalogix, Inc.
-
RosaceaPhase 2-
Signum Dermalogix, Inc.
-
Mild Atopic DermatitisPreclinical
United States
Dermata Therapeutics, Inc.Dermata Therapeutics, Inc.
01 Oct 2016
Moderate Atopic DermatitisPreclinical
United States
Dermata Therapeutics, Inc.Dermata Therapeutics, Inc.
01 Oct 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free